Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ascelia Pharma AB
AB
Active
Org 5565718797
Hyllie Boulevard 34, 215 32
Malmö
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1999 · 27 years old
11 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Ascelia Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
MO
Magnus Olafsson Corfitzen
Chief Executive Officer
Chief Executive Officer
2022
MN
Mikael Nilsson
Chief Auditor
Chief Auditor
2024
JW
Julie Waras Brogren
Chief Executive Officer
Chief Executive Officer
2020
Former (1)
CJ
Carl Johan Fredrik Fogelberg
Chief Auditor
Chief Auditor
2020 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
LG
Lauren Geyer Barnes
Board of Directors
Board of Directors
2020
HM
Hans Maier
Board of Directors
Board of Directors
2020
MK
Marianne Kock
Board of Directors
Board of Directors
2024
PJ
Peter James Arthur Benson
Chairman
Chairman
2020
AH
Anna Helena Christina Wennerström
Board of Directors
Board of Directors
2020
Former (2)
BJ
Bo Jesper Hansen
Board of Directors
Board of Directors
2020 – 2022
NM
Niels Mengel
Board of Directors
Board of Directors
2020 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ascelia Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network